^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
axitinib injectable suspension (CLS-AX)
i
Other names: CLS-AX, CLS-1002, CLS011A
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Clearside Biomedical
Drug class:
VEGF-A inhibitor, PDGFR inhibitor
Related drugs:
1year
ODYSSEY: Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration (clinicaltrials.gov)
P2b, N=60, Active, not recruiting, Clearside Biomedical, Inc. | Recruiting --> Active, not recruiting
Enrollment closed
|
Eylea (aflibercept intravitreal) • axitinib injectable suspension (CLS-AX)
Share via
